{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T03:55:26Z","timestamp":1794282926567,"version":"4.9.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.yrtph.2024.105706","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T15:05:26Z","timestamp":1726585526000},"page":"105706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Reevaluating safety pharmacology respiratory studies within the ICH S7A core battery: A multi-company evaluation of preclinical utility and clinical translation"],"prefix":"10.1016","volume":"153","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8689-1830","authenticated-orcid":false,"given":"G.S.","family":"Friedrichs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.","family":"Abernathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Ackley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.K.","family":"DaSilva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.M.","family":"Foley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Greiter-Wilke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.A","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.J.","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.H.","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Paglialunga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.K.","family":"Pugsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.P.","family":"Regan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.I.","family":"Rossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Segretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Traebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.M.","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.A.","family":"Wisialowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2024.105706_bib1","article-title":"Current nonclinical in vivo safety pharmacology testing enables safe entry to first-in-human clinical trials: the IQ consortium nonclinical to clinical translational database","author":"Ackley","year":"2018","journal-title":"Paper presented at the Safety Pharmacology Society"},{"key":"10.1016\/j.yrtph.2024.105706_bib2","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1136\/bmj.308.6943.1552","article-title":"Diagnostic tests 1: sensitivity and specificity","volume":"308","author":"Altman","year":"1994","journal-title":"Br. Med. J."},{"key":"10.1016\/j.yrtph.2024.105706_bib3","first-page":"50363","article-title":"S7A safety pharmacology studies for human pharmaceuticals. International Council for Harmonisation of technical requirements for pharmaceuticals for human use","volume":"86","year":"2001","journal-title":"Fed. Regist."},{"key":"10.1016\/j.yrtph.2024.105706_bib6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.yrtph.2009.07.010","article-title":"Respiratory safety pharmacology: positive control drug responses in Sprague\u2013Dawley rats, Beagle dogs and cynomolgus monkeys","volume":"55","author":"Authier","year":"2009","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.yrtph.2024.105706_bib7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.vascn.2013.05.002","article-title":"Safety pharmacology investigations in toxicology studies: an industry survey","volume":"68","author":"Authier","year":"2013","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.yrtph.2024.105706_bib8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.vascn.2019.03.004","article-title":"EEG: characteristics of drug-induced seizures in rats, dogs, and non-human primates","volume":"97","author":"Authier","year":"2019","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.yrtph.2024.105706_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2021.107055","article-title":"Core battery safety pharmacology testing \u2013 an assessment of its utility in early drug development","volume":"109","author":"Baldrick","year":"2021","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"1","key":"10.1016\/j.yrtph.2024.105706_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/kfz035","article-title":"Preclinical to clinical translation of hemodynamic effects in cardiovascular safety pharmacology studies","volume":"169","author":"Bhatt","year":"2019","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2024.105706_bib11","first-page":"568","article-title":"Evaluation of a clinical test. II: assessment of validity","volume":"108","author":"Chien","year":"2001","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"10.1016\/j.yrtph.2024.105706_bib12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jbi.2015.02.008","article-title":"Prediction of clinical risks by analysis of preclinical and clinical adverse events","volume":"54","author":"Clark","year":"2015","journal-title":"J. Biomed. Inf."},{"key":"10.1016\/j.yrtph.2024.105706_bib13","series-title":"Paper Presented at the Safety Pharmacology Society","article-title":"Analysis of concordance of preclinical data on nervous system and respiratory functions to Phase I trial outcomes using the Animal Model Framework","author":"Giarola","year":"2013"},{"issue":"2","key":"10.1016\/j.yrtph.2024.105706_bib14","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.vascn.2012.04.002","article-title":"Cardiorespiratory safety evaluation in non-human primates","volume":"66","author":"Ingram-Ross","year":"2012","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.yrtph.2024.105706_bib15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2131\/jts.20.77","article-title":"Predictability of clinical adverse reactions of drugs by general pharmacology studies","volume":"20","author":"Igarashi","year":"1995","journal-title":"J. Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.yrtph.2024.105706_bib16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.vascn.2008.07.001","article-title":"Benchmarking safety pharmacology regulatory packages and best practice","volume":"58","author":"Lindgren","year":"2008","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.yrtph.2024.105706_bib17","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.yrtph.2016.05.002","article-title":"Assessing the predictive value of the rodent neurofunctional assessment for commonly reported adverse events in phase I clinical trials","volume":"80","author":"Mead","year":"2016","journal-title":"Reg Tox And Path"},{"key":"10.1016\/j.yrtph.2024.105706_bib18","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.taap.2017.09.006","article-title":"Current nonclinical testing paradigm enables safe entry to First-In-Human clinical trials: the IQ consortium nonclinical to clinical translational database","volume":"334","author":"Monticello","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2024.105706_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2019.106596","article-title":"Translatability of the S7A core battery respiratory safety pharmacology studies: preclinical respiratory and related clinical adverse events","volume":"99","author":"Paglialunga","year":"2019","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.yrtph.2024.105706_bib20","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/bph.14101","article-title":"Can non-clinical repolarization assays predict the results of clinical thorough QT studies? Results from a research consortium","volume":"175","author":"Park","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.yrtph.2024.105706_bib21","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/toxsci\/kfx125","article-title":"An analysis of the relationship between preclinical and clinical QT interval-related data","volume":"159","author":"Pollard","year":"2017","journal-title":"Toxicol. Sci."},{"issue":"3","key":"10.1016\/j.yrtph.2024.105706_bib22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1472-8206.2002.00098.x","article-title":"Safety pharmacology--a progressive approach","volume":"16","author":"Redfern","year":"2002","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.yrtph.2024.105706_bib23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/978-3-662-46943-9_14","article-title":"Inclusion of safety pharmacology endpoints in repeat-dose toxicity studies","volume":"229","author":"Redfern","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"issue":"6","key":"10.1016\/j.yrtph.2024.105706_bib24","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1177\/1091581820946703","article-title":"Evaluation of respiratory rate measurements derived from arterial blood pressure waveforms in telemetered dogs","volume":"39","author":"Tang","year":"2020","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.yrtph.2024.105706_bib25","article-title":"Over two decades of ICH S7A: has the time come for a revamp","volume":"130","author":"Valentin","year":"2023","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2024.105706_bib26","first-page":"170","article-title":"Prevalence, frequency and impact of safety related issues throughout the pharmaceutical life cycle","volume":"150","author":"Valentin","year":"2017","journal-title":"Toxicologist"},{"issue":"6628","key":"10.1016\/j.yrtph.2024.105706_bib27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1126\/science.adg6276","article-title":"FDA no longer has to require animal testing for new drugs","volume":"379","author":"Wadman","year":"2023","journal-title":"Science"}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230024001478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230024001478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T06:50:04Z","timestamp":1755067804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230024001478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":25,"alternative-id":["S0273230024001478"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2024.105706","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reevaluating safety pharmacology respiratory studies within the ICH S7A core battery: A multi-company evaluation of preclinical utility and clinical translation","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2024.105706","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105706"}}